Vyndaqel 20 MG capsule UD 120S
Ended Awarded
- Contract number
- SPE2DB25FLVXD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,694
Award facts
- Contract value 100% obligated
- $27,693.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,693.94 to AmerisourceBergen Drug Corp for the supply of Vyndaqel 20 mg capsules (120-count unit doses). This firm fixed-price delivery order, issued on September 9, 2025, with completion targeted for September 30, 2025, represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award is issued under a larger Indefinite Delivery Contract vehicle—specifically the DLA Troop Support Medical SPE2DX contract valued at $999,999,999.00 and extending through December 2026—which serves as the comprehensive global pharmaceutical support mechanism for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Vyndaqel, a cardiovascular disease medication, reflects the company's role as a primary supplier within the DLA's medical supply chain supporting military and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FLVXD?
SPE2DB25FLVXD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FLVXD worth?
The government has obligated $27,694 on SPE2DB25FLVXD.
Is contract SPE2DB25FLVXD an order under another contract?
Yes. SPE2DB25FLVXD is a delivery order under SPE2DB22D6029, an indefinite delivery contract.
Was contract SPE2DB25FLVXD competed?
The extent of competition for SPE2DB25FLVXD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award